Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB)June 24, 2026Yahoo Finance
Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB)June 24, 2026Yahoo Finance
SpaceX Is Eyeing a $20 Billion Bond Sale After Its Historic IPO. What That Means for SPCX Stock Investors.June 24, 2026Yahoo Finance
SpaceX Is Eyeing a $20 Billion Bond Sale After Its Historic IPO. What That Means for SPCX Stock Investors.June 24, 2026Yahoo Finance
Bristol-Myers Squibb Company (BMY) and SystImmune Announce Results from Analyses of Iza-bren StudiesJune 24, 2026Yahoo Finance
Bristol-Myers Squibb Company (BMY) and SystImmune Announce Results from Analyses of Iza-bren StudiesJune 24, 2026Yahoo Finance
Amazon Is Navigating a $200B Spending Cycle — AMZN Stock Is Still a Buy NowJune 24, 2026Yahoo Finance
Oil prices finish 1% lower as investors focus on Hormuz flows after peace talksJune 24, 2026Yahoo Finance
